fluoxetine has been researched along with amyloid beta-peptides in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adilijiang, A; Guo, H; Guo, W; Huang, Q; Kong, J; Li, XM; Luo, G; Qiao, J; Qiu, Y; Wang, H; Wang, J; Xu, H; Zhang, R; Zhang, Y; Zhu, S | 1 |
1 other study(ies) available for fluoxetine and amyloid beta-peptides
Article | Year |
---|---|
Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP/PS1 mouse model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Astrocytes; Brain; Cells, Cultured; Disease Models, Animal; Fluoxetine; Humans; Maze Learning; Neurons; Neuroprotective Agents; Peptide Fragments; Plaque, Amyloid; Presenilin-1; Receptors, Serotonin, 5-HT2 | 2016 |